All Stories

  1. Cell Culture Systems To Study Human Herpesvirus 6A/B Chromosomal Integration

    Article • Journal of Virology, May 2017, ASM Journals

    Louis Flamand

  2. Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration

    Article • Journal of Virology, May 2017, ASM Journals

    Louis Flamand

  3. Summary of the 9th international conference on human herpesviruses 6 and 7 (HHV-6A, HHV-6B, and HHV-7)

    Article • Journal of Medical Virology, May 2016, Wiley

    Louis Flamand

  4. Inhibition of Interleukin-2 Gene Expression by Human Herpesvirus 6B U54 Tegument Protein

    Article • Journal of Virology, August 2014, ASM Journals

    Louis Flamand

  5. Inhibition of Breast Cancer Cell Proliferation through Disturbance of the Calcineurin/NFAT Pathway by Human Herpesvirus 6B U54 Tegument Protein

    Article • Journal of Virology, August 2014, ASM Journals

    Louis Flamand

  6. Editorial Commentary: Pathogenesis From the Reactivation of Chromosomally Integrated Human Herpesvirus Type 6: Facts Rather Than Fiction

    Article • Clinical Infectious Diseases, May 2014, Oxford University Press (OUP)

    Louis Flamand

  7. Influenza virus H1N1 activates platelets through Fc RIIA signaling and thrombin generation

    Article • Blood, March 2014, American Society of Hematology

    Louis Flamand

  8. Frequency of Chromosomally-Integrated Human Herpesvirus 6 in Children with Acute Lymphoblastic Leukemia

    Article • PLoS ONE, December 2013, PLOS

    Louis Flamand

  9. Classification of HHV-6A and HHV-6B as distinct viruses

    Article • Archives of Virology, November 2013, Springer Science + Business Media

    Louis Flamand

  10. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome

    Article • Journal of Medical Virology, August 2013, Wiley

    Louis Flamand

  11. Complete Genome Sequence of Early Passaged Human Herpesvirus 6A (GS Strain) Isolated from North America

    Article • Genome Announcements, June 2013, ASM Journals

    Louis Flamand

  12. Sequence Analysis of Transplacentally Acquired Human Herpesvirus 6 DNA Is Consistent With Transmission of a Chromosomally Integrated Reactivated Virus

    Article • The Journal of Infectious Diseases, February 2013, Oxford University Press (OUP)

    Louis Flamand

  13. 2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV

    Article • Journal of Leukocyte Biology, December 2012, Society for Leukocyte Biology

    Louis Flamand

  14. Chromosomally integrated human herpesvirus 6: questions and answers

    Article • Reviews in Medical Virology, November 2011, Wiley

    Louis Flamand, Dr Dirk Lassner

  15. LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects

    Article • Respiratory Medicine, July 2011, Elsevier

    Louis Flamand

  16. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4

    Article • Arthritis & Rheumatism, May 2011, Wiley

    Louis Flamand

  17. Repression of interferon-α stimulated genes expression by Kaposi's sarcoma-associated herpesvirus K-bZIP protein

    Article • Virology, December 2010, Elsevier

    Louis Flamand

  18. Herpesviruses and Chromosomal Integration

    Article • Journal of Virology, September 2010, ASM Journals

    Louis Flamand

  19. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV‐6 in post‐infective fatigue syndrome

    Article • Journal of Medical Virology, September 2010, Wiley

    Louis Flamand, prof.dr. (emeritus professor) Jaap Michiel Middeldorp

  20. Review, part 1: Human herpesvirus‐6‐basic biology, diagnostic testing, and antiviral efficacy

    Article • Journal of Medical Virology, July 2010, Wiley

    Louis Flamand

  21. Contagious Period for Pandemic (H1N1) 2009

    Article • Emerging Infectious Diseases, May 2010, Centers for Disease Control and Prevention (CDC)

    Louis Flamand

  22. Divergent susceptibilities of human herpesvirus 6 variants to type I interferons

    Article • Proceedings of the National Academy of Sciences, April 2010, Proceedings of the National Academy of Sciences

    Louis Flamand

  23. Human herpesvirus‐6 in patients with Crohn’s disease

    Article • Apmis, April 2010, Wiley

    Louis Flamand

  24. Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen Inhibits Interferon (IFN)   Expression by Competing with IFN Regulatory Factor-3 for Binding to IFNB Promoter

    Article • Journal of Biological Chemistry, January 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Louis Flamand

  25. Amphipathic DNA polymers exhibit antiviral activity against systemic Murine Cytomegalovirus infection

    Article • Virology Journal, December 2009, Springer Science + Business Media

    Louis Flamand

  26. Divergent susceptibilities of human herpesvirus 6 variants to type I interferon

    Article • Cytokine, October 2009, Elsevier

    Louis Flamand

  27. Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Necessary for Lytic Viral Gene Expression, DNA Replication, and Virion Production in Primary Effusion Lymphoma Cell Lines

    Article • Journal of Virology, March 2009, ASM Journals

    Louis Flamand

  28. Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum

    Article • Journal of Clinical Microbiology, February 2009, ASM Journals

    Louis Flamand

  29. Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro

    Article • Laboratory Investigation, February 2008, Elsevier

    Louis Flamand

  30. Increased tumorigenicity of cells carrying recombinant human herpesvirus 8

    Article • Archives of Virology, October 2007, Springer Science + Business Media

    Louis Flamand

  31. Synergistic activation of interferon‐β gene transcription by the viral FLICE inhibitory protein of Kaposi's sarcoma‐associated herpesvirus and type I IFN activators

    Article • European Journal of Immunology, September 2007, Wiley

    Louis Flamand

  32. Binding of Kaposi's Sarcoma-Associated Herpesvirus K-bZIP to Interferon-Responsive Factor 3 Elements Modulates Antiviral Gene Expression

    Article • Journal of Virology, July 2007, ASM Journals

    Louis Flamand

  33. Leukotriene B4 Triggers the In Vitro and In Vivo Release of Potent Antimicrobial Agents

    Article • The Journal of Immunology, June 2007, The American Association of Immunologists

    Louis Flamand

  34. Epitope mapping of a monoclonal antibody specific for human herpesvirus 6 variant A immediate-early 2 protein

    Article • Journal of Clinical Virology, April 2007, Elsevier

    Louis Flamand

  35. Inhibition of Transcription of the Beta Interferon Gene by the Human Herpesvirus 6 Immediate-Early 1 Protein

    Article • Journal of Virology, March 2007, ASM Journals

    Louis Flamand

  36. 15: Mapping of transactivation domains of human herpesvirus-6 immediate-early 2 protein

    Article • Journal of Clinical Virology, December 2006, Elsevier

    Louis Flamand

  37. 23: Overview of serological assays for the detection of active HHV-6 infection

    Article • Journal of Clinical Virology, December 2006, Elsevier

    Louis Flamand

  38. 14: Functional interactions between human herpesvirus-6 (HHV-6) immediate-early 2 (IE2) protein and ubiquitin-conjugating enzyme 9 (Ubc9) in the absence of sumoylation

    Article • Journal of Clinical Virology, December 2006, Elsevier

    Louis Flamand

  39. Functional Interaction between Human Herpesvirus 6 Immediate-Early 2 Protein and Ubiquitin-Conjugating Enzyme 9 in the Absence of Sumoylation

    Article • Journal of Virology, October 2006, ASM Journals

    Louis Flamand

  40. Mapping of human herpesvirus 6 immediate–early 2 protein transactivation domains

    Article • Virology, October 2006, Elsevier

    Louis Flamand

  41. Biological and clinical advances in human herpesvirus-6 and -7 research

    Article • Future Virology, September 2006, Future Medicine

    Louis Flamand

  42. Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6

    Article • Archives of Virology, February 2006, Springer Science + Business Media

    Louis Flamand

  43. Leukotriene B4 Protects Latently Infected Mice against Murine Cytomegalovirus Reactivation following Allogeneic Transplantation

    Article • The Journal of Immunology, January 2005, The American Association of Immunologists

    Louis Flamand

  44. Multiplex detection and quantitation of latent and lytic transcripts of human herpesvirus-8 using RNase Protection Assay

    Article • Journal of Virological Methods, December 2004, Elsevier

    Louis Flamand

  45. Release of Anti‐HIV Mediators after Administration of Leukotriene B 4 to Humans

    Article • The Journal of Infectious Diseases, June 2004, Oxford University Press (OUP)

    Louis Flamand

  46. Generation and characterization of a monoclonal antibody specific for human herpesvirus 6 variant A immediate–early 2 protein

    Article • Journal of Clinical Virology, December 2003, Elsevier

    Louis Flamand

  47. Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator

    Article • Virology, April 2003, Elsevier

    Louis Flamand

  48. Activation of Monocyte Cyclooxygenase-2 Gene Expression by Human Herpesvirus 6. ROLE FOR CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN AND ACTIVATOR PROTEIN-1

    Article • Journal of Biological Chemistry, June 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Louis Flamand

  49. Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4

    Article • Clinical & Experimental Immunology, December 2001, Oxford University Press (OUP)

    Louis Flamand

  50. EBV Suppresses Prostaglandin E2 Biosynthesis in Human Monocytes

    Article • The Journal of Immunology, June 2000, The American Association of Immunologists

    Louis Flamand

  51. Infection of Primary Human Monocytes by Epstein-Barr Virus

    Article • Journal of Virology, March 2000, ASM Journals

    Louis Flamand

  52. Epstein-Barr virus suppresses PGE2 release in human monocytes

    Article • Prostaglandins & Other Lipid Mediators, December 1999, Elsevier

    Louis Flamand

  53. Epstein-Barr virus infects and reduces phagocytic activity in human monocytes

    Article • Prostaglandins & Other Lipid Mediators, December 1999, Elsevier

    Louis Flamand

  54. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease

    Article • Nature Reports Stem Cells, April 1998, Springer Science + Business Media

    Louis Flamand

  55. Activation of CD8+T lymphocytes through the T cell receptor turns on CD4 gene expression: Implications for HIV pathogenesis

    Article • Proceedings of the National Academy of Sciences, March 1998, Proceedings of the National Academy of Sciences

    Louis Flamand

  56. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

    Article • Nature Reports Stem Cells, December 1997, Springer Science + Business Media

    Louis Flamand

  57. Rapid Communication: Absence of Human Herpesvirus 8 DNA Sequences in Neoplastic Kaposi's Sarcoma Cell Lines

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, October 1996, Wolters Kluwer Health

    Louis Flamand

  58. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

    Article • Journal of Clinical Investigation, March 1996, American Society for Clinical Investigation

    Louis Flamand

  59. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.

    Article • Journal of Clinical Investigation, June 1992, American Society for Clinical Investigation

    Louis Flamand

  60. Inhibition of tumor necrosis factor‐α transcription by Epstein‐Barr virus

    Article • European Journal of Immunology, January 1991, Wiley

    Louis Flamand

  61. Epstein-Barr Virus Infection and Monokine Synthesis

    Article • January 1991, Springer Science + Business Media

    Louis Flamand